Reported 5,422,820 shares, up 1,086,524 (25.1%) from the prior quarter.
Reported value -3.4%; share count 25.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 3158867 |
| 2026-03-31 | 7313456 |
| 2026-06-30 | 9010818 |
| 2026-09-30 | 8708213 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 5,422,820 | +1,086,524 (25.1%) | 0.04% | $8,708,213 | 2026-11-03 | |
| Q2 2026 | Added | 4,336,296 | +1,338,978 (44.7%) | 0.04% | $9,010,818 | 2026-08-13 | |
| Q1 2026 | Added | 2,997,318 | +691,674 (30.0%) | 0.04% | $7,313,456 | 2026-04-30 | |
| Q4 2025 | New | 2,305,644 | +2,305,644 (0.0%) | 0.02% | $3,158,867 | 2026-02-13 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
229 managers reported ALLOGENE THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 30,927,343 | +780,380 | < 0.01% | $49,483,750 | 9 qtrs |
| CITADEL ADVISORS LLC | Added | 24,558,325 | +14,470,555 | < 0.01% | $39,293,320 | 32 qtrs |
| PFIZER INC | Unchanged | 22,032,040 | 0 | 22.13% | $36,352,866 | 8 qtrs |
| Frazier Life Sciences Management L P | Unchanged | 22,446,668 | 0 | 0.89% | $35,914,669 | 11 qtrs |
| STATE STREET CORPORATION | Reduced | 16,326,197 | -2,699,629 | < 0.01% | $26,121,915 | 32 qtrs |
| PRIMECAP MANAGEMENT CO CA | Added | 13,146,840 | +23,400 | 0.01% | $21,034,944 | 24 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 12,050,271 | -116,365 | < 0.01% | $19,280,434 | 3 qtrs |
| UBS Group AG | Added | 10,704,296 | +7,665,904 | < 0.01% | $17,126,874 | 32 qtrs |
| FMR LLC | Reduced | 10,599,559 | -1,409,484 | < 0.01% | $16,959,295 | 32 qtrs |
| Sio Capital Management LLC | Reduced | 9,104,151 | -4,219,280 | 2.76% | $14,566,642 | 2 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 03, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 5,422,820
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.